
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Psychiatrist Elizabeth Ford, MD, describes the evacuation of psychiatric inpatients from Bellevue Hospital in the immediate aftermath of Hurricane Sandy.
To listen,




